TG Therapeutics Ownership | Who Owns TG Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

TG Therapeutics Ownership Summary

TG Therapeutics is owned by 42.47% institutional investors, 6.78% insiders, and 50.74% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 14.52% of TGTX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.08% of its assets in TG Therapeutics shares.

TGTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	TG Therapeutics	42.47%	6.78%	50.74%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	21.30M	14.52%	$769.48M
Vanguard group	15.52M	10.58%	$560.71M
Blackrock	11.39M	7.79%	$202.60M
State street	8.10M	5.52%	$292.63M
Clearbridge investments	4.64M	3.17%	$167.78M
Soleus capital management	3.84M	2.62%	$138.89M
Geode capital management	3.44M	2.35%	$125.04M
Bank of america corp /de/	2.08M	1.42%	$37.04M
Pictet asset management sa	1.91M	1.30%	$68.65M
Nuveen asset management	1.80M	1.24%	$54.15M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
M28 capital management lp	161.60K	8.58%	$5.84M
Soleus capital management	3.84M	6.99%	$138.89M
Ghost tree capital	500.00K	2.79%	$8.89M
Opaleye management	535.00K	2.73%	$19.33M
Pandora wealth	78.30K	1.71%	$2.83M
Cornerstone select advisors	55.28K	1.47%	$2.00M
Penn capital management company	443.37K	1.38%	$16.00M
Iridian asset management llc/ct	75.29K	1.07%	$2.72M
Quantum private wealth	98.91K	1.04%	$3.57M
Spotlight asset group	82.10K	1.02%	$1.46M

Top Buyers

Holder	Shares	% Assets	Change
Soleus capital management	3.84M	6.99%	1.60M
Clearbridge investments	4.64M	0.13%	1.59M
Man group	1.01M	0.06%	868.70K
Balyasny asset management	696.13K	0.04%	696.13K
Blackrock	11.39M	0.00%	544.84K

Top Sellers

Holder	Shares	% Assets	Change
Marshall wace, llp	-	-	-2.05M
Deep track capital, lp	-	-	-1.73M
Wellington management group llp	60.60K	0.00%	-1.17M
Vestal point capital, lp	-	-	-1.05M
Fmr	711.34K	0.00%	-840.63K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	401.50K	0.00%	401.50K	$12.09M
Bridgewater associates, lp	342.15K	0.05%	342.15K	$12.36M
Hrt financial lp	108.28K	0.01%	108.28K	$3.91M
Schroder investment management group	79.96K	0.00%	79.96K	$2.94B
Aquatic capital management	75.49K	0.05%	75.49K	$2.73M

Sold Out

Holder	Change
Global financial private client	-2.00
Mendota financial group	-4.00
Financial gravity asset management	-5.00
Dinuzzo private wealth	-8.00
Continuum advisory	-15.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	238	-35.68%	62,326,392	-35.80%	42	0.97%	92	-50.27%	94	-7.84%
Jun 30, 2025	376	-4.08%	101,484,974	3.38%	69	1.54%	187	-6.50%	105	-10.26%
Mar 31, 2025	390	10.48%	98,223,511	1.40%	66	1.50%	200	6.38%	116	20.83%
Dec 31, 2024	194	-40.49%	60,970,728	-39.60%	42	0.87%	109	-42.02%	53	-28.38%
Sep 30, 2024	325	18.18%	100,828,838	8.07%	69	1.67%	187	30.77%	74	10.45%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	8.06M	5.08%	-
Vanguard Total Stock Mkt Idx Inv	4.52M	2.86%	-95.21K
Vanguard US Total Market Shares ETF	4.36M	2.78%	3.80K
iShares Russell 2000 ETF	3.50M	2.20%	-
Vanguard Small Cap Index	3.47M	2.19%	-23.18K
SPDR® S&P Biotech ETF	2.30M	1.45%	5.12K
Vanguard Small Cap Growth Index Inv	1.95M	1.24%	-4.82K
Pictet Biotech	1.79M	1.16%	1.79M
Vanguard Institutional Extnd Mkt Idx Tr	1.46M	0.92%	-633.82K
Fidelity Small Cap Index	1.46M	0.92%	41.92K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 24, 2025	Echelard Yann	-	Sell	$162.85K
Sep 11, 2025	Lonial Sagar	-	Sell	$672.27K
Jun 13, 2025	Echelard Yann	-	Sell	$369.40K
Jan 03, 2025	Power Sean A	CFO	Sell	$343.44K
Jan 06, 2025	Power Sean A	CFO	Sell	$285.94K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	1
2025 Q3	-	1
2025 Q2	-	1
2025 Q1	-	2
2024 Q4	-	3

TGTX Ownership FAQ

Who Owns TG Therapeutics?

TG Therapeutics shareholders are primarily institutional investors at 42.47%, followed by 6.78% insiders and 50.75% retail investors. The average institutional ownership in TG Therapeutics's industry, Biotech Stocks , is 45.22%, which TG Therapeutics falls below.

Who owns the most shares of TG Therapeutics?

TG Therapeutics’s largest shareholders are Blackrock funding, inc. /de (21.3M shares, 14.52%), Vanguard group (15.52M shares, 10.58%), and Blackrock (11.39M shares, 7.79%). Together, they hold 32.88% of TG Therapeutics’s total shares outstanding.

Does Blackrock own TG Therapeutics?

Yes, BlackRock owns 7.79% of TG Therapeutics, totaling 11.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 202.6M$. In the last quarter, BlackRock increased its holdings by 544.84K shares, a 5.02% change.

Who is TG Therapeutics’s biggest shareholder by percentage of total assets invested?

M28 capital management lp is TG Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.58% of its assets in 161.6K TG Therapeutics shares, valued at 5.84M$.

Who is the top mutual fund holder of TG Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of TG Therapeutics shares, with 5.08% of its total shares outstanding invested in 8.06M TG Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools